Quick Answer
GALECTIN THERAPEUTICS INC reported Earnings Per Share Diluted of $0.48 (loss) per share for the year ending 2025.
- GALECTIN THERAPEUTICS INC showed an increase of +36.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from GALECTIN THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), GALECTIN THERAPEUTICS INC's Earnings Per Share Diluted has declined by 17.1%.
- Historical annual values: Fiscal year 2025: $0.48 (loss) per share | Fiscal year 2024: $0.76 (loss) per share | Fiscal year 2023: $0.74 (loss) per share | Fiscal year 2022: $0.65 (loss) per share | Fiscal year 2021: $0.52 (loss) per share | Fiscal year 2020: $0.41 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: